UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral disease modifying therapy for multiple sclerosis; is this the new normal?

Value in health, 2015-05, Vol.18 (3), p.A290-A291

Johnson, B.H

2015

Volltextzugriff (PDF)

And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

Value in health, 2014-05, Vol.17 (3), p.A66-A66

Johnson, B.H

2014

Volltextzugriff (PDF)

Testing For Children With Pharyngitis; Improving Trends Towards Appropriate Antibiotic Use

Value in health, 2014-05, Vol.17 (3), p.A169-A169

2014

Volltextzugriff (PDF)

Continuous glucose monitoring systems: Trends in uptake, patient costs, and resource utilization

Value in health, 2014-05, Vol.17 (3), p.A245-A245

2014

Volltextzugriff (PDF)

Direct Medical Burden And Readmission Rates Among Non-Elderly Patients With Acute Ischemic Stroke In The United States

Value in health, 2015-05, Vol.18 (3), p.A139-A139

2015

Volltextzugriff (PDF)

Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US

Value in health, 2014-11, Vol.17 (7), p.A391-A391

2014

Volltextzugriff (PDF)

Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

Value in health, 2013-11, Vol.16 (7), p.A621-A621

2013

Volltextzugriff (PDF)

Annual Incidence Rates of Herpes Zoster among an Immunocompetent Population In The United States

Value in health, 2015-05, Vol.18 (3), p.A232-A232

2015

Volltextzugriff (PDF)

Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population

Value in health, 2014-05, Vol.17 (3), p.A46-A47

2014

Volltextzugriff (PDF)

Health care resource utilization and costs in patients initiating natalizumab therapy for multiple sclerosis in the United States

Value in health, 2013-05, Vol.16 (3), p.A104-A104

2013

Volltextzugriff (PDF)

PND74 - Oral disease modifying therapy for multiple sclerosis; is this the new normal?

Value in health, 2015-05, Vol.18 (3), p.A290-A291

Johnson, B.H.

2015

Volltextzugriff (PDF)

Measuring The Burden Of Herpes Zoster In The United States Among An Immunocompetent Population

Value in health, 2014-05, Vol.17 (3), p.A271-A272

2014

Volltextzugriff (PDF)

Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis

Value in health, 2013-05, Vol.16 (3), p.A111-A111

2013

Volltextzugriff (PDF)

PND55 - And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

Value in health, 2014-05, Vol.17 (3), p.A66-A66

Johnson, B.H.

2014

Volltextzugriff (PDF)

PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USE

Value in health, 2011, Vol.14 (3), p.A124-A124

2011

Volltextzugriff (PDF)

PSY25 Health Care Resource Utilization (HRU) and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus (SLE) in a Medicaid Population in the United States

Value in health, 2012-06, Vol.15 (4), p.A103-A103

2012

Volltextzugriff (PDF)

Clinical and economic outcomes with appropriate or partial prophylaxis

Thrombosis research, 2010-06, Vol.125 (6), p.513-517

2010

Volltextzugriff (PDF)

PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINE

Value in health, 2011, Vol.14 (3), p.A95-A95

2011

Volltextzugriff (PDF)

PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta Agonists

Value in health, 2012-06, Vol.15 (4), p.A60-A61

2012

Volltextzugriff (PDF)

PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

Value in health, 2011, Vol.14 (3), p.A49-A49

2011

Volltextzugriff (PDF)

PRS41 A REAL-WORLD EVALUATION OF BETA AGONIST USE DURING HOSPITALIZATIONS FOR COPD

Value in health, 2011, Vol.14 (3), p.A144-A144

2011

Volltextzugriff (PDF)

PIH88 - Testing For Children With Pharyngitis; Improving Trends Towards Appropriate Antibiotic Use

Value in health, 2014-05, Vol.17 (3), p.A169-A169

2014

Volltextzugriff (PDF)

PDB45 - Continuous glucose monitoring systems: Trends in uptake, patient costs, and resource utilization

Value in health, 2014-05, Vol.17 (3), p.A245-A245

2014

Volltextzugriff (PDF)

PMD48 ROBOTIC TOTAL HYSTERECTOMY: ASSOCIATION OF SURGICAL INDICATION WITH USE OF ROBOTIC-ASSISTANCE AND RELATED HEALTHCARE RESOURCE UTILIZATION AND COSTS

Value in health, 2020-05, Vol.23, p.S198-S198

2020

Volltextzugriff (PDF)

PMD5 COMPARATIVE EFFECTIVENESS ASSESSMENT OF TWO POWERED SURGICAL STAPLING PLATFORMS IN LAPAROSCOPIC SLEEVE GASTRECTOMY

Value in health, 2020-05, Vol.23, p.S188-S189

2020

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(210)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(237)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(75)
Animals
(33)
Biological And Medical Sciences
(31)
Physical Sciences
(29)
Male
(27)
Internal Medicine
(23)
Physics
(23)
Humans
(22)
Agriculture
(21)
Fundamental And Applied Biological Sciences. Psychology
(20)
Female
(19)
Technology
(16)
Reproductive Biology
(13)
Medical Sciences
(12)
Chemistry
(11)
Veterinary Sciences
(11)
Agriculture, Dairy & Animal Science
(10)
Biochemistry & Molecular Biology
(9)
Experiment
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oral disease modifying therapy for multiple sclerosis; is this the new normal?

And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

Testing For Children With Pharyngitis; Improving Trends Towards Appropriate Antibiotic Use

Continuous glucose monitoring systems: Trends in uptake, patient costs, and resource utilization

Direct Medical Burden And Readmission Rates Among Non-Elderly Patients With Acute Ischemic Stroke In The United States

Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US

Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

Annual Incidence Rates of Herpes Zoster among an Immunocompetent Population In The United States

Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population

Health care resource utilization and costs in patients initiating natalizumab therapy for multiple sclerosis in the United States

PND74 - Oral disease modifying therapy for multiple sclerosis; is this the new normal?

Measuring The Burden Of Herpes Zoster In The United States Among An Immunocompetent Population

Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis

PND55 - And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USE

PSY25 Health Care Resource Utilization (HRU) and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus (SLE) in a Medicaid Population in the United States

Clinical and economic outcomes with appropriate or partial prophylaxis

PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINE

PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta Agonists

PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

PRS41 A REAL-WORLD EVALUATION OF BETA AGONIST USE DURING HOSPITALIZATIONS FOR COPD

PIH88 - Testing For Children With Pharyngitis; Improving Trends Towards Appropriate Antibiotic Use

PDB45 - Continuous glucose monitoring systems: Trends in uptake, patient costs, and resource utilization

PMD48 ROBOTIC TOTAL HYSTERECTOMY: ASSOCIATION OF SURGICAL INDICATION WITH USE OF ROBOTIC-ASSISTANCE AND RELATED HEALTHCARE RESOURCE UTILIZATION AND COSTS

PMD5 COMPARATIVE EFFECTIVENESS ASSESSMENT OF TWO POWERED SURGICAL STAPLING PLATFORMS IN LAPAROSCOPIC SLEEVE GASTRECTOMY

Suchergebnisse filtern